يعرض 1 - 10 نتائج من 409 نتيجة بحث عن '"D. D. Von Hoff"', وقت الاستعلام: 1.04s تنقيح النتائج
  1. 1
    دورية أكاديمية
    BIOLOGICAL EFFECTS OF ACETOMYCIN I. ACTIVITY AGAINST TUMOR CELLS IN VITRO AND IN VIVO

    المؤلفون: D. D. VON HOFF, G. C. HOKANSON, J. B. TUNAC, J. C. FRENCH, J. D. MITULSKI, J. L. SHILLIS, K. L. HAMELEHLE, S. W. MAMBER, W. R. LEOPOLD

    المصدر: The Journal of Antibiotics. 1987, 40(1):73

    View record in JSTAGE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas

    المؤلفون: R. K. Ramanathan, D. Goldstein, R. L. Korn, F. Arena, M. Moore, S. Siena, L. Teixeira, J. Tabernero, J. L. Van Laethem, H. Liu, D. Mcgovern, B. Lu, D. D. Von Hoff

    المساهمون: R.K. Ramanathan, D. Goldstein, R.L. Korn, F. Arena, M. Moore, S. Siena, L. Teixeira, J. Tabernero, J.L. Van Laethem, H. Liu, D. Mcgovern, B. Lu, D.D. Von Hoff

    مصطلحات موضوعية: gemcitabine, metabolic response, nab-paclitaxel, pancreatic cancer, positron emission tomography, oncology, hematology, Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26802153; info:eu-repo/semantics/altIdentifier/wos/WOS:000374237700013; volume:27; issue:4; firstpage:648; lastpage:653; numberofpages:6; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2434/423401Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84964636352

    الإتاحة: https://doi.org/10.1093/annonc/mdw020Test
    http://hdl.handle.net/2434/423401Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    © 2003 European Society for Medical Oncology A phase I study of bizelesin, a highly potent and selective DNA- interactive agent, in patients with advanced solid malignancies

    المؤلفون: G. H. Schwartz, A. Patnaik, L. A. Hammond, J. Rizzo, K. Berg, D. D. Von Hoff, E. K. Rowinsky

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: http://annonc.oxfordjournals.org/content/14/5/775.full.pdfTest.

    وصف الملف: application/pdf

    العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.580.7938Test; http://annonc.oxfordjournals.org/content/14/5/775.full.pdfTest

    الإتاحة: http://annonc.oxfordjournals.org/content/14/5/775.full.pdfTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    A phase Ib/II trial of high dose ascorbic acid (AA) + paclitaxel protein bound (PP) + cisplatin (C) + gemcitabine (G) with digital spatial profiling (DSP) in patients (pts) with metastatic pancreatic cancer (MPC)

    المؤلفون: D. D. Von Hoff, Gayle S. Jameson

    المصدر: European Journal of Cancer. 138:S55

    مصطلحات موضوعية: Cisplatin, Cancer Research, Oncology, Paclitaxel protein-bound, Chemistry, Metastatic pancreatic cancer, medicine, Cancer research, In patient, Ascorbic acid, Gemcitabine, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::77e93b5304fad2db82c52f6f766d365aTest
    https://doi.org/10.1016/s0959-8049Test(20)31224-7


    أضف إلى المفضلة
  5. 5
    A Multi-Center Phase IIA Trial to Assess the Safety and Efficacy of BL-8040 (a CXCR4 Inhibitor) in Combination with Pembrolizumab and Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma (PDAC)

    المؤلفون: Jaime Feliu, D. Gutierrez Abad, Teresa Macarulla, Shaul Kadosh, Bruno Bockorny, Y. Gozlan, M. Ponz Sarvise, Ella Sorani, A.V. Vainstein, Amnon Peled, Osnat Bohana-Kashtan, Marya F. Chaney, Manuel Hidalgo, Valerya Semenisty, Erkut Borazanci, D. D. Von Hoff

    المصدر: Annals of Oncology. 30:xi33

    مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, education.field_of_study, business.industry, Population, Hematology, Pembrolizumab, Chemotherapy regimen, Gemcitabine, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, Fluorouracil, 030220 oncology & carcinogenesis, Internal medicine, Cohort, medicine, Part-time employment, business, education, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::685df07c3749de9fbe9684788557f7b4Test
    https://doi.org/10.1093/annonc/mdz451Test


    أضف إلى المفضلة
  6. 6
    A phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC)

    المؤلفون: Katia Schlienger, Mitesh J. Borad, Amnon Peled, Manuel Hidalgo, Brian M. Wolpin, Ravit Geva, A. Vainstein Haras, O. Bohana Kashtan, J.O. Park, Ella Sorani, Talia Golan, Tzipora M. Lustig, Katrina S. Pedersen, D. D. Von Hoff, O. Rosenfeld, Salomon M. Stemmer, Ron Epelbaum, Erkut Borazanci, Robert A. Ramirez

    المصدر: Annals of Oncology. 29:viii402

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Hematology, Pembrolizumab, Metastatic Pancreatic Adenocarcinoma, 01 natural sciences, 0104 chemical sciences, 010404 medicinal & biomolecular chemistry, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, PHASE IIA TRIAL, In patient, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a0f3a35356efedbe8e945356aa08009fTest
    https://doi.org/10.1093/annonc/mdy288.006Test


    أضف إلى المفضلة
  7. 7
    Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors

    المؤلفون: C. Storgard, D. Toft, D. D. Von Hoff, Tomislav Dragovich, David S. Mendelson, Charles Erlichman, Francis Burrows, Muhammad Wasif Saif

    المصدر: Cancer Chemotherapy and Pharmacology. 71:1345-1355

    مصطلحات موضوعية: Adult, Male, Drug, Cancer Research, Maximum Tolerated Dose, Receptor, ErbB-2, Lactams, Macrocyclic, media_common.quotation_subject, Antineoplastic Agents, Pharmacology, Toxicology, Pharmacokinetics, Neoplasms, Benzoquinones, polycyclic compounds, Humans, Medicine, HSP70 Heat-Shock Proteins, Pharmacology (medical), In patient, HSP90 Heat-Shock Proteins, Infusions, Intravenous, Receptor, Aged, media_common, Dose-Response Relationship, Drug, biology, business.industry, Ansamycin, Middle Aged, Hsp90, female genital diseases and pregnancy complications, Hsp70, Clinical trial, Oncology, Leukocytes, Mononuclear, biology.protein, Nanoparticles, Emulsions, Female, business, Biomarkers

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e93f95c30aefa50ccf7b2275aed178daTest
    https://doi.org/10.1007/s00280-013-2134-9Test


    أضف إلى المفضلة
  8. 8
    Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

    المؤلفون: C. F. Shelton, E. G. Chiorean, Donald L. Durden, Stephen P. Anthony, A. Stejskal-Barnett, Daruka Mahadevan, F. Cordova, Wenqing Qi, Joseph R. Garlich, M. D. Becker, Ramesh K. Ramanathan, Wayne Harris, D. M. Rensvold, D. D. Von Hoff, A. E. Younger

    المصدر: European Journal of Cancer. 48:3319-3327

    مصطلحات موضوعية: Adult, Male, Drug, Cancer Research, Maximum Tolerated Dose, Gastrointestinal Diseases, media_common.quotation_subject, Salvage therapy, Antineoplastic Agents, Hypokalemia, Mechanistic Target of Rapamycin Complex 1, Pharmacology, Biology, Article, Young Adult, Pharmacokinetics, Neoplasms, medicine, Humans, Prodrugs, Molecular Targeted Therapy, Infusions, Intravenous, Protein Kinase Inhibitors, B cell, Aged, Phosphoinositide-3 Kinase Inhibitors, media_common, Aged, 80 and over, Salvage Therapy, Dose-Response Relationship, Drug, TOR Serine-Threonine Kinases, Proteins, Middle Aged, Prodrug, medicine.disease, Hematologic Diseases, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm Proteins, Lymphoma, Leukemia, medicine.anatomical_structure, Oncology, Chromones, Multiprotein Complexes, Pharmacodynamics, Female, Lymphoma, Large B-Cell, Diffuse, Oligopeptides

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1122ebca542d2c3e2bed39e5819823eTest
    https://doi.org/10.1016/j.ejca.2012.06.027Test


    أضف إلى المفضلة
  9. 9
    PD-023Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

    المؤلفون: David Z. Chang, Vincent Chung, Navreet Dhindsa, Khalid Mamlouk, Richard A. Hubner, Andrea Wang-Gillam, Niall C. Tebbutt, D. D. Von Hoff, Fabio Franke, Prasad Cooray, Bruce Belanger, Paul Ross, L.-T. Chen, Tomislav Dragovich, Shubham Pant, Jens T. Siveke, F. de Jong

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Phases of clinical research, Hematology, Gemcitabine, 03 medical and health sciences, Abstracts, 030104 developmental biology, 0302 clinical medicine, Text mining, Pancreatic Cancer Stage IV, Fluorouracil, 030220 oncology & carcinogenesis, Internal medicine, Metastatic pancreatic cancer, medicine, Previously treated, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66aeffc01089ae994dc557598aa69350Test
    https://europepmc.org/articles/PMC4984171Test/


    أضف إلى المفضلة
  10. 10
    Final results of NAPOLI-1 : A phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

    المؤلفون: Teresa Macarulla, D. D. Von Hoff, Andrea Wang-Gillam, Jean-Frédéric Blanc, C.-P. Li, Eliel Bayever, F. de Jong, Kiheon Lee, G. Bodoky, Y.-S. Shan, Gilberto Schwartsmann, F. Braiteh, Richard A. Hubner, Jens T. Siveke, Andrew Dean, L.-T. Chen, David Cunningham, Bruce Belanger, Gayle S. Jameson, Chang Fang Chiu

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Medizin, Phases of clinical research, Hematology, Gemcitabine, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Fluorouracil, 030220 oncology & carcinogenesis, Internal medicine, Metastatic pancreatic cancer, medicine, Previously treated, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d9b2b822af1fe3b49ea1ef1b64c858Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث